4139.Two

4139.TWO has a debt-to-equity ratio of 1.13, indicating a moderate level of leverage, while its current ratio of 0.57 suggests potential liquidity constraints. The company's free cash flow of 97,192,000 TWD demonstrates some cash generation capability, but its operating cash flow of 238,899,000 TWD is not sufficient to cover its long-term debt of 501,152,000 TWD. The negative net cash position after subtracting total debt raises concerns about its short-term liquidity.

Profitability metrics show a return on equity of -0.1518 and a return on assets of -0.0486, both of which are negative, indicating that the company is not generating returns for its shareholders or assets. These figures are below the typical performance expected in the healthcare industry, suggesting underperformance relative to its peers.

The company's revenue is concentrated in a single segment, as no additional segments are disclosed, and there is no geographic breakdown provided in the available data. This lack of diversification could expose the company to higher risk if its primary market experiences downturns.

Looking at the growth trajectory, the company's most recent revenue of 1,092,508,000 TWD is higher than the analyst estimate of 942,569,000 TWD, indicating some positive momentum. However, the operating income of -44,371,000 TWD and net income of -67,082,000 TWD suggest that the company is still not profitable and may face challenges in sustaining growth.

The risk assessment highlights medium liquidity risk and low dilution risk, but the key flag of negative net cash after total debt is a significant concern. The company has not disclosed any dilution sources, and the low dilution risk suggests that there is currently no immediate threat of share dilution.

Recent events include the latest financial report showing a revenue of 1,092,508,000 TWD, which is above the analyst estimate, but the company remains unprofitable with negative operating and net income. No recent filings or transcripts are available to provide further insight into the company's strategic direction or operational performance.